期刊文献+

枸橼酸碳酸氢盐血液透析液对外周细胞因子和NOS的影响 被引量:2

Influence upon peripheral cytokine and NOS of citric acid bicarbonate hemodialysate
下载PDF
导出
摘要 目的:研究枸橼酸碳酸氢盐血液透析液对外周细胞因子和一氧化氮合成酶的影响。方法:对30例维持性血液透析的患者采取自身前后对照研究,前4周行醋酸碳酸氢盐透析液透析(对照组),后4周行枸橼酸碳酸氢盐透析液透析(实验组)。观察透析前后单核细胞数量的变化;透析前、后及第4周透析后,测定外周血IL-1β、TNF-α及TNOS和iNOS的吸光度,分别计算TNOS和iNOS的活力。结果:透析后实验组单核细胞数明显下降;透析前两组TNF-α、IL-1β、TNOS和iNOS水平没有差异,透析后及第4周透析后,对照组增高均较实验组明显。结论:枸橼酸碳酸氢盐血液透析液能减少透析过程中单核细胞和内皮细胞功能的激活。 Objective: To study influence on eytokine and nitric oxide synthase(NOS) of citric acid and bicarbonate hemodialysate . Metheds: Thirty maintenance hemidialysis patients were included in this self- control study , patients were administrated with bicarbonate hemodialysate acidified with acetic acid for the first four weeks as the test group and then with citrate hemodialysate acidified with citric acid for the last four weeks as the control group. The serum monocyte amounts of two groups were measured before hemodialysis and after hemodialysis. The serum of levels IL-1, TNF-α, TNOS and iNOS optical density were determined and the activities of TNOS and NOS were calculated at pre-hemodialysis, post-hemodialysis and the fourth week. Results : The serum monocyte amount of.the test group significantly decreased in comparison with control group after hemodialysis. There was no difference in the levels of serum IL-1, TNF-α, TNOS and iNOS between two groups before hemodialysis and significantly increased in control group after hemodialysis and at 4-week hemodialysis. Conclusion: The citric acid and bicarbonate hemodialysate decrease monocyte and endotheliocyte functional activation during dialysis session.
出处 《陕西医学杂志》 CAS 2009年第3期303-305,共3页 Shaanxi Medical Journal
关键词 肾透析 枸橼碳酸氢盐 细胞因子类 一氧代氮合酶 透析液 Renal clialysis @Citric acid bicarbonate Cgto kines Nitric-oxicle synthase Dialysis solutions
  • 相关文献

参考文献7

  • 1Veech RL. The untoward effects of the anions dialysis fluids .Kidney Int, 1988, 34: 587-597.
  • 2肖申,季大玺,季曙明,胡维新.醋酸盐和无醋酸碳酸氢盐血透病人外周血IL-6、TNF和淋巴细胞亚群的变化[J].中华肾脏病杂志,1995,11(3):163-165. 被引量:9
  • 3Pizzarelli F, Cerrai T, Ferro G, et al . On-line hemodiafiltration without acetate. G Ital Nefrol, 2004, 21 Suppl 30:S97-101.
  • 4陈香美,张冬.应重视维持性血液透析患者微炎症状态的认识[J].中国血液净化,2005,4(2):59-61. 被引量:102
  • 5Boenisch O,Ehmke KD, Heddergott A, et al . C-reactive protein levels in hemodialysis patients. J Am Soc Nephrol, 2002, 15:547-551.
  • 6Amore A, Conti G, Cirina P, et al. Biocompatibility of the acetate in the dialysis fluid . G Ital Nefrol, 2004, 21 Suppl 30:S91-96.
  • 7Amore A, Cirina P, Mitola S,et al . Acetate intolerance is mediated by enhanced synthesis of nitric oxide by endothelial cells. J Am Soc Nephrol, 1997, 8:1431- 1436.

二级参考文献11

  • 1吕伯东,胡青,马寅峰,杨克冰,张士更,赵晓黎,张清芳,许凌宇,王寅,朱琮.新型光量子对血透患者慢性炎症反应状态的干预作用[J].中国中西医结合肾病杂志,2004,5(10):581-582. 被引量:14
  • 2季大玺,肾脏病与透析肾移植杂志,1993年,2卷,230页
  • 3Yeun J Y, Levine RA, Mantadilok N, et al. C - reactive protein predicts all cause and cardiovascular mortality in hemodialysis patients. Am H Kidney Dis,2000,35:469 - 476
  • 4Stenvinkel P, Heimburger O, Paultre F, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int, 1999,55:1899- 1911
  • 5Pereita B J, Shapito L, King A J, et al. Plasma levels of IL - 1beta,TNF - α and the irspecific inhibitors in undialyzed chronic renal failure,CAPD and hemodialysis patients. Kidney Int, 1994,45: 890- 896
  • 6Ortega O, Rodriguez I, Gallar P, etal. Significance of high C- reactiveprotein levels in pre-dialysis patients. Nephrol Dial Transplant,2002,17(6): 1105 - 1109
  • 7Boenisch O, Ehmke K D, Heddergott A, et al. C - reactive protein and cytokine plasma levels in hemodialysis patients. J Am Soc Nephrol,2002,15:547 - 551
  • 8Kaysen G A. The micro inflammatory state in uremia: cause and potential consequences. J Am Soc Nephrol,2001,12(7): 1549 - 1557
  • 9Sezer S, Ozdemir F N, Arat Z, et al. Triad of malnutrition, inflammation, and atherosclerosis in hemodialysis patients. Nephron, 2002, 91 (3): 456-462
  • 10Owen, Lowrie RA, Mantadilok V, et al. C - reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int, 1998,54(2) :627

共引文献109

同被引文献28

  • 1丁琼,张守柱,阚明,吴永贵.维持性血液透析患者同型半胱氨酸超敏C反应蛋白及肿瘤坏死因子与动脉粥样硬化关系[J].安徽医科大学学报,2007,42(5):559-561. 被引量:7
  • 2Agarwal R, Nissenson A R, Batlle D, et al. Prevalence, treat-ment ,and control of hypertension in chronic hemodialysis patientsin the United States[J]. Am J Med, 2003,115(4) :291 -7.
  • 3Barbi J’ Pardoll D,Pan F. Metabolic control of the Treg/Thl7 ax-is [J]. Immunol Rev, 2013,252(1) : 52-77.
  • 4Furuya R, Kumagai H, Miyata T, et al. High plasma pentosidinelevel is accompanied with cardiovascular events in hemodialysispatients [ J]. Clin Exp Nephrol, 2012, 16(3) :421 -6.
  • 5Liu Z, Zhao Y, Wei F, et al. Treatment with telmisartan/rosuvas-tatin combination has a beneficial synergistic effect on ameliorating1^17/Treg functional imbalance in hypertensive patients with ca-rotid atherosclerosis [J]. Atherosclerosis, 2014, 233(1) :291 -9.
  • 6Li Q, Wang Y, Yu F,et al. Peripheral Thl7/Treg imbalance inpatients with atherosclerotic cerebral infarction [ J ]. Int J Clin ExpPathol, 2013,6(6);1015-27.
  • 7Chen D, Huang X,Yang M,et al. Treg/Thl7 functional disequi-librium in Chinese uremia on hemodialysis; a link between calcifi-cation and cardiovascular disease[ J]. Ren Fail, 2012, 34(6):697 -702.
  • 8Leurs P, Lindholm B, Stenvinkel P. Effects of hemodiaiiltrationon uremic inflammation [J]. Blood Purif, 2013,35 Suppl 1:11-7.
  • 9Tomo T. Preferred dialysis fluid for the high-performance mem-brane [J]. Contrib Nephrol,2011,173 : 44 -52.
  • 10Saito T, Saito 0,Maeda T, et al. Metabolic and hemodynamic ad-vantages of an acetate-free citrate dialysate in a uremic case of con-genital methylmalonic academia [ J ] _ Am J Kidney Dis,2009, 54(4): 764 -9.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部